Mepitel Film Versus StrataXRT in Managing Radiation Dermatitis in an Intra‐Patient Controlled Clinical Trial of 80 Postmastectomy Patients
Journal of Medical Imaging and Radiation Oncology · 2025
DOI: 10.1111/1754-9485.13850 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, 2025. Verfasst von Patries Herst und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Therapy, University of Otago, Wellington, New Zealand. Hauptthemen laut MEDLINE: Radiodermatitis, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Medicine (MJ), University of Otago, Christchurch, the Canterbury Regional Cancer and Haematology Service (MvS, RT, KD, KM, FJ), Christchurch Hosp…, Department of Radiation Therapy (PH) and the Biostatistics group (RW), University of Otago, Wellington, Molnlycke Health Ltd and Stratpharma Ltd generously donated Mepitel film and StrataXRT free of costs.
Abstract (Originalsprache)
Background
Mepitel film decreases the severity of radiation dermatitis in breast cancer patients, but its application is resource‐intensive. Many departments therefore use StrataXRT, a gel that patients apply themselves. We compared the protective effects of Mepitel film and StrataXRT on radiation dermatitis during and immediately after radiation therapy.
Methods
This phase III multicentre randomised intra‐patient‐controlled clinical trial recruited breast cancer patients receiving radiation therapy following mastectomy in three New Zealand Hospitals. Lateral and medial aspects of the chest wall were randomised to either Mepitel film or StrataXRT. Overall skin reaction severity was measured using RISRAS and RTOG once a week during treatment and for 4 weeks after treatment completion. The primary outcome was moist desquamation (with a non‐inferiority margin of 7.5%); secondary outcomes were overall skin reaction severity, patient tolerability, satisfaction and cost.
Results
Between June 2021 and May 2024, 93 patients were recruited, and 80 patients completed the trial. The absolute difference in moist desquamation rates was 6% lower under Mepitel film ( p = 0.413, 95% CI ‐5%, 18%). Overall skin reaction severity was significantly lower for Mepitel film (Researcher RISRAS: p = 0.022; RTOG: p = 0.011). Mepitel film was cheaper to apply but was less well tolerated, with poor skin adherence being an issue for many patients.
Conclusion
The study did not show non‐inferiority for StrataXRT; overall skin reaction severity and costs were significantly lower under Mepitel film; however, StrataXRT was better tolerated. Trial Registration: ACTRN12621000124831
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Therapy, University of Otago, Wellington, New Zealand.
- Canterbury Regional Cancer and Haematology Service, Christchurch Hospital, Christchurch, New Zealand.
- Regional Cancer Treatment Service, Palmerston North Hospital, Palmerston North, New Zealand.
- Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand.
- Biostatistics Group, University of Otago, Wellington, New Zealand.
- Department of Medicine, Christchurch Hospital, University of Otago Christchurch, Christchurch, New Zealand.
ORCID-Profile: Patries Herst, Melissa James
Förderung
- Department of Medicine (MJ), University of Otago, Christchurch, the Canterbury Regional Cancer and Haematology Service (MvS, RT, KD, KM, FJ), Christchurch Hosp…
- Department of Radiation Therapy (PH) and the Biostatistics group (RW), University of Otago, Wellington
- Molnlycke Health Ltd and Stratpharma Ltd generously donated Mepitel film and StrataXRT free of costs
Zitieren
APA
Herst, P., van Schalkwyk, M., Baker, N., Thyne, R., Dunne, K., Moore, K., Jackson, F., Beaven, K., Rutten, L., McKee, G., Willink, R., & James, M. (2025). Mepitel Film Versus StrataXRT in Managing Radiation Dermatitis in an Intra‐Patient Controlled Clinical Trial of 80 Postmastectomy Patients. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/1754-9485.13850
Vancouver
Herst P, van Schalkwyk M, Baker N, Thyne R, Dunne K, Moore K, et al. Mepitel Film Versus StrataXRT in Managing Radiation Dermatitis in an Intra‐Patient Controlled Clinical Trial of 80 Postmastectomy Patients. Journal of Medical Imaging and Radiation Oncology. 2025. doi:10.1111/1754-9485.13850
BibTeX
@article{Herst2025,
author = {Herst, Patries and van Schalkwyk, Mary and Baker, Natasha and Thyne, Rebecca and Dunne, Kelly and Moore, Kylie and Jackson, Freya and Beaven, Kendal and Rutten, Lucy and McKee, Gemma and Willink, Robin and James, Melissa},
title = {Mepitel Film Versus StrataXRT in Managing Radiation Dermatitis in an Intra‐Patient Controlled Clinical Trial of 80 Postmastectomy Patients},
journal = {Journal of Medical Imaging and Radiation Oncology},
year = {2025},
doi = {10.1111/1754-9485.13850}
}
EUVIMED